Rhinitis and asthma comorbidity in Spain: The RINAIR study

Archivos de Bronconeumologia

Volumn 44, Issue 11, 2008, Pages 597-603

  Castillo Vizuete, José Antonio ^a,b,e   Miret, Joaquim Mullol ^b,c,d  

^a INSTITUT UNIVERSITARI DEXEUS   (Spain)

^b SEPAR

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e NONE   (Spain)

Author keywords

Asthma; Comorbidity; Exacerbation; Lung function; Rhinitis; Treatment

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; ALLERGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; ATOPY; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PREVALENCE; RHINITIS; SPAIN; EPIDEMIOLOGY; HAY FEVER; IMMEDIATE TYPE HYPERSENSITIVITY; MIDDLE AGED; PERENNIAL RHINITIS; PROSPECTIVE STUDY; PULMONOLOGY; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLERGENS; ASTHMA; COMORBIDITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY MEDICINE; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SAMPLING STUDIES; SPAIN; YOUNG ADULT;

EID: 55949106160     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1157/13128326     Document Type: Article

References (29)

1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens J, Togías A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008;63 Suppl 86:8-160.
2. Togias A. Rhinitis and asthma; evidence for respiratory system integration. J Allergy Clin Immunol. 2003;111:1171-83.
3. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24:758-64.
4. Alergológica 2005. Factores epidemiológicos, clínicos y socioeconómicos de las enfermedades alérgicas en España en 2005. Madrid: Egraf SA; 2006.
5. Bousquet J, van Cauwenberge P, Ait Khaled N, Bachert C, Baena-Cagnani CE, Bouchard J, et al. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy. 2006;61:1086-96.
6. Global Strategy for Asthma Management and Prevention. Update from NHLB/WHO Workshop report 1995. GINA, 2002. NIH Publication No. 02-3659. Available from www.ginasthma.com
7. Guillemany JM, Mullol J, Picado C. Relaciones entre rinosinusitis y bronquiectasias. Arch Bronconeumol. 2006;42:135-40.
8. Guilemany JM, Alobid I, Centelles S, Angrill J, Berenguer J, Bernal-Sprekelsen M, et al. One airway, one disease: high prevalence of chronic rhinosinusitis and nasal polyposis in patients with bronchiectasis. Allergy. 2007;62 Suppl 83:117.
9. Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol. 2002;109:57-62.
10. Corren J, Manning BE, Thompson SF, Hennessy S, Strom BL. Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol. 2004;113:415-9.
11. Plaza Moral V, Álvarez Gutiérrez FJ, Casan Clarà P, Cobos Barroso N, López Viña A, Llauger Roselló MA, et al. Guía Española para el Manejo del Asma. Arch Bronconeumol. 2004;40:72-9.
12. Borderias Clau L, Zabaleta Murguionda M, Riesco Miranda JA, Pellicer Ciscar C, Hernández Hernández JR, Carrillo Díaz T, et al. Coste y manejo de una crisis asmática en el ámbito hospitalario de nuestro medio (estudio COAX en servicios hospitalarios). Arch Bronconeumol. 2005;41:707-9.
13. Dreborg S, Frew A. Skin prick test. Position paper of the European Academy of Allergology and Clinical Immunology. Allergy. 1993;48 Suppl 14:49-54.
14. Linneberg A, Henrik-Nielsen N, Frolund L, Madsen F, Dirksen A, Jorgensen T. The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy study. Allergy. 2002;57:1048-52.
15. Guerra S, Sherrill DL, Martínez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol. 2002;109:419-25.
16. Gelfand EW. Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol. 2004;114:S135-S8.
17. Braunstahl GJ, Prins JB, Kleinjan A, Overbeek SE, Hoogsteden HC, Fokkens WJ. Nose and lung cross-talk in allergic airways disease. Clin Exp Allergy Rev. 2003;3:38-42.
18. Leynaert B, Neukirch C, Kony S, Guénégou A, Bousquet J, Aubier M, et al. Association between asthma and rhinitis according to atopic sensitization in a population-based study. J Allergy Clin Immunol. 2004;113:86-93.
19. Leynaert B, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects. Results from the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1999;104:301-4.
20. Borderías L, García-Ortega P, Badia X, Casafont J, Gambús G, Roset M, et al. Diagnóstico de asma alérgica en consultas de alergología y neumología. Gac Sanit. 2006;20:435-41.
21. Espinosa MJ, González A, Rodríguez R, Ancochea J. Análisis descriptivo (características clínicas y funcionales) de la población asmática de un área sanitaria. Arch Bronconeumol. 1999;35:518-24.
22. Sunyer J, Antó JM, Castellsagué J, Soriano JB, Roca J; Spanish Group of the European Study of Asthma. Total serum IgE is associated with asthma independently of specific IgE levels. Eur Respir J. 1996;9:1880-4.
23. Nihén U, Greiff L, Montnémery P, Löfdahl CG, Johannisson A, Persson C, et al. Incidence and remission of self-reported allergic rhinitis symptoms in adults. Allergy. 2006;61:1299-304.
24. Schramm B, Ehlken B, Smala A, Quednau K, Bergeer K, Nowak D. Cost of asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J. 2003;21:116-22.
25. Price D, Zhang Q, Kocevar VS, Yin DD, Thomas M. Effect of concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy. 2005;35:282-7.
26. Taramarcaz P, Gibson PG. The effectiveness of intranasal corticosteroids in combined allergic rhinitis and asthma syndrome. Clin Exp Allergy. 2004;34:1883-9.
27. Price DB, Swern A, Tozzi CA, Phipi G, Polos P. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy. 2006;61:737-42.
28. Busse WW, Casale TB, Dykewicz MS, Meltzer EO, Bird SR, Hustad CM, et al. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity. Ann Allergy Asthma Immunol. 2006;96:60-8.
29. Borderías L, Mincewicz G, Paggiaro PL, Guilera M, Sazonov Kocevar V, Taylor SD, et al. Asthma control in patients with asthma and allergic rhinitis receiving add-on montelukast therapy for 12 months: a retrospective study. Curr Med Res Opin. 2007;23:721-30.